Residency · New Brunswick, NJ
Sponsored by Rutgers Health
Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline.
Practical radiation oncology · 2024 · 144 citations · Madeera Kathpal
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
ESMO open · 2022 · 289 citations · Salma Jabbour
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 230 citations · Matthew Deek
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
The Lancet. Oncology · 2022 · 226 citations · Salma Jabbour
Controlling Gastric Cancer in a World of Heterogeneous Risk.
Gastroenterology · 2023 · 101 citations · Haejin In
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
JAMA oncology · 2021 · 224 citations · Salma Jabbour
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026 · 19 citations · Salma Jabbour
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 89 citations · Bruce Haffty